Analytical performance specifications for external quality assessment – definitions and descriptions

Abstract External Quality Assurance (EQA) is vital to ensure acceptable analytical quality in medical laboratories. A key component of an EQA scheme is an analytical performance specification (APS) for each measurand that a laboratory can use to assess the extent of deviation of the obtained results from the target value. A consensus conference held in Milan in 2014 has proposed three models to set APS and these can be applied to setting APS for EQA. A goal arising from this conference is the harmonisation of EQA APS between different schemes to deliver consistent quality messages to laboratories irrespective of location and the choice of EQA provider. At this time there are wide differences in the APS used in different EQA schemes for the same measurands. Contributing factors to this variation are that the APS in different schemes are established using different criteria, applied to different types of data (e.g. single data points, multiple data points), used for different goals (e.g. improvement of analytical quality; licensing), and with the aim of eliciting different responses from participants. This paper provides recommendations from the European Federation of Laboratory Medicine (EFLM) Task and Finish Group on Performance Specifications for External Quality Assurance Schemes (TFG-APSEQA) and on clear terminology for EQA APS. The recommended terminology covers six elements required to understand APS: 1) a statement on the EQA material matrix and its commutability; 2) the method used to assign the target value; 3) the data set to which APS are applied; 4) the applicable analytical property being assessed (i.e. total error, bias, imprecision, uncertainty); 5) the rationale for the selection of the APS; and 6) the type of the Milan model(s) used to set the APS. The terminology is required for EQA participants and other interested parties to understand the meaning of meeting or not meeting APS.

[1]  Sverre Sandberg,et al.  Defining analytical performance specifications 15 years after the Stockholm conference , 2015, Clinical chemistry and laboratory medicine.

[2]  Sverre Sandberg,et al.  Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine , 2015, Clinical chemistry and laboratory medicine.

[3]  Marc H M Thelen,et al.  Expressing analytical performance from multi-sample evaluation in laboratory EQA , 2017, Clinical chemistry and laboratory medicine.

[4]  Graham Rd Jones,et al.  'Allowable Limits of Performance' for External Quality Assurance Programs - an Approach to Application of the Stockholm Criteria by the RCPA Quality Assurance Programs. , 2012, The Clinical biochemist. Reviews.

[5]  Mario Plebani,et al.  Quality specifications in EQA schemes: from theory to practice. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[6]  Graham Ross Dallas Jones Analytical performance specifications for EQA schemes – need for harmonisation , 2015, Clinical chemistry and laboratory medicine.

[7]  Anders Kallner,et al.  STRATEGIES TO SET GLOBAL ANALYTICAL QUALITY SPECIFICATION, IN LABORATORY MEDICINE , 1999 .

[8]  P. H. Petersen,et al.  External quality assessment: currently used criteria for evaluating performance in European countries, and criteria for future harmonization. , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[9]  Sverre Sandberg,et al.  Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference , 2017, Clinical chemistry and laboratory medicine.

[10]  S. Sandberg,et al.  External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe , 2011, Clinical chemistry and laboratory medicine.

[11]  Cas Weykamp,et al.  Proficiency testing/external quality assessment: current challenges and future directions. , 2011, Clinical chemistry.